Lack of interferon response in animals to naked siRNAs
- 21 November 2004
- journal article
- letter
- Published by Springer Nature in Nature Biotechnology
- Vol. 22 (12), 1579-1582
- https://doi.org/10.1038/nbt1038
Abstract
RNA interference (RNAi) is rapidly becoming the method of choice for the elucidation of gene function and the identification of drug targets. As with other oligonucleotide-based strategies, RNAi is envisioned to ultimately be useful as a human therapeutic. Unlike previous nucleic acid therapeutics, small interfering RNAs have the potential to elicit immune responses via interactions with Toll-like receptor 3 and trigger interferon responses like long, double-stranded RNA and its analogs, such as poly(I:C)1. Recently, the safety of siRNAs has been questioned because they have been shown to trigger an interferon response in cultured cells2,3,4,5. We show here that it is possible to administer naked, synthetic siRNAs to mice and downregulate an endogenous or exogenous target without inducing an interferon response.Keywords
This publication has 30 references indexed in Scilit:
- Interferon induction by siRNAs and ssRNAs synthesized by phage polymeraseNature Biotechnology, 2004
- Small-interfering RNAs in the radar of the interferon systemNature Cell Biology, 2003
- Activation of the interferon system by short-interfering RNAsNature Cell Biology, 2003
- Induction of an interferon response by RNAi vectors in mammalian cellsNature Genetics, 2003
- Expression profiling reveals off-target gene regulation by RNAiNature Biotechnology, 2003
- RNA interference targeting Fas protects mice from fulminant hepatitisNature Medicine, 2003
- Toll-like receptors as potential therapeutic targets for multiple diseasesNature Reviews Drug Discovery, 2002
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3Nature, 2001
- Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature, 2001